Cargando…
GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy
Interest in gene-based therapies for neurodevelopmental disorders is increasing exponentially, driven by the rise in recognition of underlying genetic etiology, progress in genomic technology, and recent proof of concept in several disorders. The current prioritization of one genetic disorder over a...
Autores principales: | Chopra, Maya, Modi, Meera E., Dies, Kira A., Chamberlin, Nancy L., Buttermore, Elizabeth D., Brewster, Stephanie Jo, Prock, Lisa, Sahin, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478871/ https://www.ncbi.nlm.nih.gov/pubmed/36156879 http://dx.doi.org/10.1016/j.omtm.2022.08.007 |
Ejemplares similares
-
Meta-analysis and multidisciplinary consensus statement: exome
sequencing is a first-tier clinical diagnostic test for individuals with
neurodevelopmental disorders
por: Srivastava, Siddharth, et al.
Publicado: (2019) -
Correction: Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
por: Srivastava, Siddharth, et al.
Publicado: (2020) -
Toward representative genomic research: the children’s rare disease cohorts experience
por: Frazier, Zoë J., et al.
Publicado: (2023) -
Editorial: Biomarkers to Enable Therapeutics Development in Neurodevelopmental Disorders
por: Sahin, Mustafa, et al.
Publicado: (2020) -
Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders
por: Davidson, Beverly L., et al.
Publicado: (2022)